Displaying 21 to 28 of 28 investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
ProteinSimple ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. |
1 Apr 2009 | Series C |
|||
ProteinSimple ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. |
1 Oct 2010 | Series F |
|||
PTC Therapeutics Inc Biopharmaceutical company. |
United States | N/A |
|||
Santaris Pharma A/S |
Denmark | 1 Jun 2012 | Venture Initial investment. Round participant. Active |
||
Symphogen |
Denmark | 1 Feb 2011 | Series F Follow-on investment. Round participant. Active |
||
Symphogen |
Denmark | 1 Jan 2006 | Series D Initial investment. Round participant. Active |
||
Synosia Therapeutics Develops innovative treatments for disorders of the central nervous system |
United States | N/A |
|||
Tobira Therapeutics Inc Dedicated to the clinical development of antiviral products |
United States | 1 Sep 2010 | Series B |